← Leaderboards
Christopher Joseph Schaber
Soligenix, Inc.
$954,020
Attributed
$954,020
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300K · FY2009–14$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$954,020 · 3
By mechanism
R43$954,020 · 3
Top collaborators
No co-investigators on record.
Most similar at Soligenix, Inc.
Same institution · by research overlap
- Kevin James Horgan$1,337,803
- Oreola Donini$1,916,410
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionChronicBreathingMedicalClinical TrialsAcuteOralAffectResponsePublic Health RelevanceAbdomenClinically SignificantCohortClinical ResearchCellsAdverse EffectsCessation Of LifeBeclomethasone DipropionateAbsorptionAnorexiaAbdominal PainCancer TherapyBiological AvailabilityApplications Grants
Grant awards (4)
Innate Defense Regulator Peptide as a Therapeutic for Acute Pneumonic Melioidosis$300,000
R43 · FY2014 · AI · contact PI
IND 20212 (03-25-99) PHASE 2: ORBEC (ORAL BDP)-PATIENTS WITH CHRONIC GVHD$144,150
R43 · FY2013 · CA · contact PI
Enteric-Coated Oral Beclomethasone Dipropionate in Patients with Acute Enteritis$258,635
R43 · FY2010 · CA · contact PI
Enteric-Coated Oral Beclomethasone Dipropionate in Patients with Acute Enteritis$251,235
R43 · FY2009 · CA · contact PI